Leveraging in-depth analyst evaluations, we have distilled key insights from expert assessments to provide a compelling outlook for HIVE. Our analysts point to weakening fundamentals and unfavorable market sentiment, indicating considerable downside risk in the near term. Based on this in-depth expert analysis, we hold a highly cautious view of this stock. Our conclusion: HIVE is a Strong Sell candidate.
HIVE price ended at $0.072201 on 星期三, after rising 3%
On Feb 11, 2026 00:00, the price of HIVE rose by 3%, climbing from $0.072927 to $0.072201 with 24h trading volume reaching $2.1M HIVE.
